skip to content
Leprosy Post-Exposure Prophylaxis with Single-dose Rifampicin Health economic aspects in India Preview this item
ClosePreview this item
Checking...

Leprosy Post-Exposure Prophylaxis with Single-dose Rifampicin Health economic aspects in India

Author: Anuj Tiwari
Publisher: Erasmus University Rotterdam 2020-09-09
Edition/Format: Book Book : English
Summary:
textabstractLeprosy is a preventable infectious disease, but still pose a public health challenge in India. Every year, more than 100,000 new cases are detected in India which are around 60% of the global leprosy burden. Among new cases, around 3.5% new cases are detected very late after developing a severe form of disability. The objective of the thesis was to study the health economic aspects of leprosy prevention  Read more...
Rating:

(not yet rated) 0 with reviews - Be the first.

Find a copy online

Links to this item

Find a copy in the library

We were unable to get information about libraries that hold this item.

Details

Document Type: Book
All Authors / Contributors: Anuj Tiwari
ISBN: 978-94-6361-452-8
Language Note: English
Unique Identifier: 8662849775
Awards:

Abstract:

textabstractLeprosy is a preventable infectious disease, but still pose a public health challenge in India. Every year, more than 100,000 new cases are detected in India which are around 60% of the global leprosy burden. Among new cases, around 3.5% new cases are detected very late after developing a severe form of disability. The objective of the thesis was to study the health economic aspects of leprosy prevention through post-exposure prophylaxis (PEP) with single-dose rifampicin (SDR). The Leprosy Post-Exposure Prophylaxis program (LPEP) was a multi-centre study, included India where single-dose rifampicin was administered to the contacts of the leprosy patients. We found that SDR is feasible to implement along with the national leprosy control programme. The unit cost of SDR delivery is not high and it is also cost-effective from short (5 years) to long-term (25 years). The cost-effectiveness of SDR is even further expected to improve in the high disability burden areas, due to increased chance of disability prevention. We recommend to scale-up SDR in India, ascertain cost-effectiveness of SDR in other endemic countries, and develop a leprosy elimination investment case.

Reviews

User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


\n\n

Primary Entity<\/h3>\n
<http:\/\/www.worldcat.org\/oclc\/8662849775<\/a>> # Leprosy Post-Exposure Prophylaxis with Single-dose Rifampicin Health economic aspects in India<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Book<\/a>, schema:CreativeWork<\/a> ;\u00A0\u00A0\u00A0\nlibrary:oclcnum<\/a> \"8662849775<\/span>\" ;\u00A0\u00A0\u00A0\nrdfs:comment<\/a> \"949 $l doctoralthesis<\/span>\" ;\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/10525974999#Thing\/prevention<\/a>> ; # Prevention<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/10525974999#Thing\/leprosy<\/a>> ; # Leprosy<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/10525974999#Thing\/cost_effectiveness<\/a>> ; # Cost-effectiveness<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/10525974999#Thing\/health_system<\/a>> ; # Health system<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/10525974999#Thing\/post_exposure_prophylaxis<\/a>> ; # Post-exposure prophylaxis<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/10525974999#Thing\/single_dose_rifampicin<\/a>> ; # Single-dose rifampicin<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/10525974999#Thing\/cost<\/a>> ; # Cost<\/span>\n\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/10525974999#Thing\/hansen_disease<\/a>> ; # Hansen disease<\/span>\n\u00A0\u00A0\u00A0\nschema:creator<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/10525974999#Person\/tiwari_anuj<\/a>> ; # Anuj Tiwari<\/span>\n\u00A0\u00A0\u00A0\nschema:datePublished<\/a> \"2020\/09\/09<\/span>\" ;\u00A0\u00A0\u00A0\nschema:description<\/a> \"textabstractLeprosy is a preventable infectious disease, but still pose a public health challenge in India. Every year, more than 100,000 new cases are detected in India which are around 60% of the global leprosy burden. Among new cases, around 3.5% new cases are detected very late after developing a severe form of disability. The objective of the thesis was to study the health economic aspects of leprosy prevention through post-exposure prophylaxis (PEP) with single-dose rifampicin (SDR). The Leprosy Post-Exposure Prophylaxis program (LPEP) was a multi-centre study, included India where single-dose rifampicin was administered to the contacts of the leprosy patients. We found that SDR is feasible to implement along with the national leprosy control programme. The unit cost of SDR delivery is not high and it is also cost-effective from short (5 years) to long-term (25 years). The cost-effectiveness of SDR is even further expected to improve in the high disability burden areas, due to increased chance of disability prevention. We recommend to scale-up SDR in India, ascertain cost-effectiveness of SDR in other endemic countries, and develop a leprosy elimination investment case.<\/span>\" ;\u00A0\u00A0\u00A0\nschema:exampleOfWork<\/a> <http:\/\/worldcat.org\/entity\/work\/id\/10525974999<\/a>> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Leprosy Post-Exposure Prophylaxis with Single-dose Rifampicin Health economic aspects in India<\/span>\" ;\u00A0\u00A0\u00A0\nschema:productID<\/a> \"8662849775<\/span>\" ;\u00A0\u00A0\u00A0\nschema:publication<\/a> <http:\/\/www.worldcat.org\/title\/-\/oclc\/#PublicationEvent\/erasmus_university_rotterdam2020_09_09<\/a>> ;\u00A0\u00A0\u00A0\nschema:publisher<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/10525974999#Agent\/erasmus_university_rotterdam<\/a>> ; # Erasmus University Rotterdam<\/span>\n\u00A0\u00A0\u00A0\nschema:url<\/a> <http:\/\/hdl.handle.net\/1765\/128810<\/a>> ;\u00A0\u00A0\u00A0\nschema:workExample<\/a> <http:\/\/worldcat.org\/isbn\/978-94-6361-452-8<\/a>> ;\u00A0\u00A0\u00A0\nwdrs:describedby<\/a> <http:\/\/www.worldcat.org\/title\/-\/oclc\/8662849775<\/a>> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n\n

Related Entities<\/h3>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/10525974999#Agent\/erasmus_university_rotterdam<\/a>> # Erasmus University Rotterdam<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nbgn:Agent<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Erasmus University Rotterdam<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/10525974999#Person\/tiwari_anuj<\/a>> # Anuj Tiwari<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Person<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Anuj Tiwari<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/10525974999#Thing\/cost<\/a>> # Cost<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Thing<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Cost<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/10525974999#Thing\/cost_effectiveness<\/a>> # Cost-effectiveness<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Thing<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Cost-effectiveness<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/10525974999#Thing\/hansen_disease<\/a>> # Hansen disease<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Thing<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Hansen disease<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/10525974999#Thing\/health_system<\/a>> # Health system<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Thing<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Health system<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/10525974999#Thing\/leprosy<\/a>> # Leprosy<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Thing<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Leprosy<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/10525974999#Thing\/post_exposure_prophylaxis<\/a>> # Post-exposure prophylaxis<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Thing<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Post-exposure prophylaxis<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/10525974999#Thing\/prevention<\/a>> # Prevention<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Thing<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Prevention<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/experiment.worldcat.org\/entity\/work\/data\/10525974999#Thing\/single_dose_rifampicin<\/a>> # Single-dose rifampicin<\/span>\n\u00A0\u00A0\u00A0\u00A0a \nschema:Thing<\/a> ;\u00A0\u00A0\u00A0\nschema:name<\/a> \"Single-dose rifampicin<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/hdl.handle.net\/1765\/128810<\/a>>\u00A0\u00A0\u00A0\nrdfs:comment<\/a> \"NARCIS<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/worldcat.org\/isbn\/978-94-6361-452-8<\/a>>\u00A0\u00A0\u00A0\u00A0a \nschema:ProductModel<\/a> ;\u00A0\u00A0\u00A0\nschema:isbn<\/a> \"978-94-6361-452-8<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/www.worldcat.org\/title\/-\/oclc\/#PublicationEvent\/erasmus_university_rotterdam2020_09_09<\/a>>\u00A0\u00A0\u00A0\u00A0a \nschema:PublicationEvent<\/a> ;\u00A0\u00A0\u00A0\nschema:organizer<\/a> <http:\/\/experiment.worldcat.org\/entity\/work\/data\/10525974999#Agent\/erasmus_university_rotterdam<\/a>> ; # Erasmus University Rotterdam<\/span>\n\u00A0\u00A0\u00A0\nschema:startDate<\/a> \"2020-09-09<\/span>\" ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n
<http:\/\/www.worldcat.org\/title\/-\/oclc\/8662849775<\/a>>\u00A0\u00A0\u00A0\u00A0a \ngenont:InformationResource<\/a>, genont:ContentTypeGenericResource<\/a> ;\u00A0\u00A0\u00A0\nschema:about<\/a> <http:\/\/www.worldcat.org\/oclc\/8662849775<\/a>> ; # Leprosy Post-Exposure Prophylaxis with Single-dose Rifampicin Health economic aspects in India<\/span>\n\u00A0\u00A0\u00A0\nschema:dateModified<\/a> \"2020-10-30<\/span>\" ;\u00A0\u00A0\u00A0\nvoid:inDataset<\/a> <http:\/\/purl.oclc.org\/dataset\/narcis<\/a>> ;\u00A0\u00A0\u00A0\u00A0.\n\n\n<\/div>\n\n

Content-negotiable representations<\/p>\n